GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Jinxin Fertility Group Ltd (HKSE:01951) » Definitions » EBIT

Jinxin Fertility Group (HKSE:01951) EBIT : HK$595 Mil (TTM As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Jinxin Fertility Group EBIT?

Jinxin Fertility Group's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2023 was HK$244 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$595 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Jinxin Fertility Group's annualized ROC % for the quarter that ended in Dec. 2023 was 1.92%. Jinxin Fertility Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 14.21%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Jinxin Fertility Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 5.47%.


Jinxin Fertility Group EBIT Historical Data

The historical data trend for Jinxin Fertility Group's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jinxin Fertility Group EBIT Chart

Jinxin Fertility Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial 620.05 429.75 586.61 252.58 594.92

Jinxin Fertility Group Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 322.58 312.57 -45.20 351.31 243.61

Competitive Comparison of Jinxin Fertility Group's EBIT

For the Medical Care Facilities subindustry, Jinxin Fertility Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jinxin Fertility Group's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Jinxin Fertility Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Jinxin Fertility Group's EV-to-EBIT falls into.



Jinxin Fertility Group EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$595 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jinxin Fertility Group  (HKSE:01951) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Jinxin Fertility Group's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

ROC % (Q: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2023 ) + Invested Capital (Q: Dec. 2023 ))/ count )
=465.09 * ( 1 - 33.68% )/( (16009.563 + 16055.209)/ 2 )
=308.447688/16032.386
=1.92 %

where

Invested Capital(Q: Jun. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=16658.68 - 740.253 - ( 1144.304 - max(0, 1778.548 - 1687.412+1144.304))
=16009.563

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=16293.124 - 617.878 - ( 932.884 - max(0, 1848.304 - 1468.341+932.884))
=16055.209

Note: The Operating Income data used here is two times the semi-annual (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Jinxin Fertility Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2023  Q: Dec. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=487.222/( ( (3440.725 + max(-746.091, 0)) + (3416.358 + max(-666.487, 0)) )/ 2 )
=487.222/( ( 3440.725 + 3416.358 )/ 2 )
=487.222/3428.5415
=14.21 %

where Working Capital is:

Working Capital(Q: Jun. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(102.233 + 51.13 + 135.794) - (740.253 + 0 + 294.995)
=-746.091

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(79.94 + 68.282 + 136.693) - (617.878 + 0 + 333.524)
=-666.487

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Jinxin Fertility Group's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2023 )
=594.917/10882.879
=5.47 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jinxin Fertility Group EBIT Related Terms

Thank you for viewing the detailed overview of Jinxin Fertility Group's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Jinxin Fertility Group (HKSE:01951) Business Description

Traded in Other Exchanges
Address
No. 301, North Jingsha Road, Jinjiang District, Sichuan, Chengdu, CHN
Jinxin Fertility Group Ltd is an investment holding company. Along with its subsidiaries, it is engaged in providing IVF services in both China and the United States. The firm generates its revenue from Assisted reproductive services, management services, and ancillary medical services. Geographically, it generates a majority of its revenue from the People's Republic of China.
Executives
Jinxin Fertility Investment Group Limited 2101 Beneficial owner
Hrc Investment Holding, Llc
Hhlr Advisors, Ltd. 2102 Investment manager
Hhlr Fund, L.p. 2101 Beneficial owner
Morgan Stanley 2201 Interest of corporation controlled by you
Blackrock, Inc. 2201 Interest of corporation controlled by you
Hillhouse Capital Advisors, Ltd. 2102 Investment manager
Gaoling Fund, L.p. 2101 Beneficial owner

Jinxin Fertility Group (HKSE:01951) Headlines

No Headlines